Clinical Trials · NCT03051009

Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

Name: Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Desmopressin

Phase: Phase 3
Recruitment status: Completed
Sponsor: Ferring Pharmaceuticals
Enrollment: 503
Start date: Jan 2017
Locations: 1 site, Japan
Primary endpoint: The frequency and severity of adverse events

View Desmopressin compound reference